Company

Higher Medicine

Biotechnology Research Maryland /, Delaware, United States 5 employees

Employees: 5
Contacts: 2
Emails: 2
Phones: 1

LinkedIn Crunchbase

Higher Medicine Overview

Headquarters: Maryland /, Delaware, United States
Industry: Biotechnology Research
Employees: 5
Founded: 2024
Funding: 100.0K
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

About Higher Medicine

www.HigherMedicine.Bio Higher Medicine is advancing clinics-ready small molecules for pediatric and neurodegenerative disorders, starting with Kabuki syndrome and Friedreich’s ataxia. Our lead programs—an LSD1 inhibitor and a p38 MAP kinase inhibitor—are supported by substantial safety and clinical data, enabling a de-risked entry into Phase 2a trials by 2026. With $200K raised and $2.1M in soft commitments, we’re closing a $2M pre-seed round to complete IND-enabling steps. Backed by top-tier advisors and collaborators at Johns Hopkins and UPenn, we offer a capital-efficient path to near-term proof-of-concept data and long-term impact across autism, Alzheimer’s, and health span extension.

Higher Medicine Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage
Phone contacts: 1; 25.0% coverage

Higher Medicine Org Chart

Sample employees and titles

Name	Title	Location	Contact
Andrew Andsager	Finance Student at the University	Athens, Georgia, United States	View
Kyla Lee	Pharmacy Student - Business Assistant		View
Leo Kim	Founder and CEO of Higher Medicine	Elkton, Maryland, United States	Email Phone
Timothy Dore	Innovative Scientist - Experienced	Andover, Massachusetts, United States	Email